Lv4
490 积分 2026-06-05 加入
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial
1个月前
已完结
In vivo characterization of RC28-E, a fusion protein targeting VEGF and bFGF: Pharmacokinetics and ocular distribution in primates
1个月前
已完结
不同批次的重组诱饵型受体创新药物RC28-E1与RC28-E2对视网膜新生血管的药效学比较及机制
1个月前
已完结
Abstract 5542: Novel PD-1xVEGFxIL-2 trispecific immune modulator with superior safety and greater efficacy
1个月前
已完结
Engineering CAR-NK Cells to Overcome Tumor Microenvironment (TME) Barriers in Solid Tumors
1个月前
已完结
605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models
2个月前
已完结
SOT201: cis -acting PD-1/IL-15 mutein-based immunocytokine under investigational study in solid tumors
2个月前
已完结
DSC Derived (Ea & ΔG) Energetics and Aggregation Predictions for mAbs
2个月前
已完结
Extended duration of VEGF inhibition with aflibercept 8 mg: the role of reduced ocular clearance
2个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2个月前
已完结
皖公网安备34019202002308
